BioUtah News
-
GO Utah – FYI
The Utah Governor’s Office of Economic Opportunity has renamed its Salesforce grant application and customer service portals as…
-
Cytiva Expands in Cache County
The Utah Governor’s Office of Economic Opportunity (Go Utah) and the Economic Development Corporation of Utah (EDCUtah) are…
-
BioHive Flying High
Newly released data from the University of Utah’s Kem C. Gardner Policy Institute shows that Utah’s mature life…
-
The Point Framework Plan
Last month, The Point of the Mountain released its latest Framework Plan.
-
Dan Lundergan named CEO of University of Utah Health hospitals and clinics
Dan Lundergan, MHA, COO at University of Utah Health Hospitals and Clinics, has been appointed to the role of CEO.…
-
BlueWind Medical enrolls 100th patient in OASIS study of Renova iStim system
BlueWind Medical has announced that the 100th patient has been enrolled in its OASIS (Overactive bladder stimulation system)…
-
US Ski, Snowboard Team Uses R-Zero Disinfectant System
Last month, BioUtah News and Events reported that the U.S. Ski and Snowboard Team would be using R-Zero’s…
-
Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy
Peer-reviewed results describe the Company’s test being used to confirm the presence of the virus on community waste,…
-
U.S. Rep. Burgess Owens Spends a Day in the BioHive
On Monday, U.S. Rep. Burgess Owens (R-UT-4) spent the day visiting a number of life sciences companies -…
-
Mountain Pacific Announces New Funding Opportunities
Ron Heffernan, Managing Partner at Mountain Pacific Partners recently announced the launch of Mountain Pacific’s newest funds.
-
PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer
World-renowned neurologist and movement disorders specialist joins PhotoPharmics as company advances breakthrough device through pivotal clinical trial and…
-
Renalytix Appoints Daniel J. Levangie to its Board of Directors
Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic.
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
